Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Peptides. 2011 Oct 31;32(12):2377–2383. doi: 10.1016/j.peptides.2011.09.024

Figure 4.

Figure 4

Effects of the hMC3R transmembrane domain cysteine residue mutations on NDP-MSH binding affinity and potency. Panel A shows the NDP-MSH binding affinity at these mutants. Panel B shows the ability of NDP-MSH stimulated cAMP production at these mutants. Data points represent the mean ± SE of three independent experiments with duplicate wells.